Prostaglandin E2 and patent ductus arteriosus in premature infants
Background Patent ductus arteriosus (PDA) is a congenital heart disease most commonly occurring in premature infants. Spontaneous ductus arteriosus (DA) closure in premature infants has been suggested to be associated with duct lumen maturity and the DA sensitivity to prostaglandin E2 (PGE2). Object...
Saved in:
Main Authors: | Mochammading Mochammading (Author), Risma Kerina Kaban (Author), Piprim Basarah Yanuarso (Author), Mulyadi Djer (Author) |
---|---|
Format: | Book |
Published: |
Indonesian Pediatric Society Publishing House,
2016-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transcatheter vs. surgical closure of patent ductus arteriosus: outcomes and cost analysis
by: Mulyadi M Djer, et al.
Published: (2013) -
Intravenous paracetamol and patent ductus arteriosus closure in preterm infants
by: Rizky Adriansyah, et al.
Published: (2017) -
Abdominal surgery in premature infants with patent ductus arteriosus
by: Carlos Hernández Díaz, et al.
Published: (2019) -
Management of Patent Ductus Arteriosus in Premature Infants in 2020
by: Sarah Parkerson, et al.
Published: (2021) -
Patent Ductus Arteriosus in Preterm Infants
by: Jia-Yuh Chen
Published: (2012)